357 related articles for article (PubMed ID: 24936144)
1. Expression, regulation and function of microRNAs in multiple sclerosis.
Ma X; Zhou J; Zhong Y; Jiang L; Mu P; Li Y; Singh N; Nagarkatti M; Nagarkatti P
Int J Med Sci; 2014; 11(8):810-8. PubMed ID: 24936144
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs involved in multiple sclerosis.
Siegel SR; Mackenzie J; Chaplin G; Jablonski NG; Griffiths L
Mol Biol Rep; 2012 May; 39(5):6219-25. PubMed ID: 22231906
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-7188-5p and miR-7235 regulates Multiple sclerosis in an experimental mouse model.
Ibrahim HM; AlZahrani A; Hanieh H; Ahmed EA; Thirugnanasambantham K
Mol Immunol; 2021 Nov; 139():157-167. PubMed ID: 34543842
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
5. The
Xu G; Mo L; Wu C; Shen X; Dong H; Yu L; Pan P; Pan K
Ren Fail; 2019 Nov; 41(1):955-966. PubMed ID: 31658856
[No Abstract] [Full Text] [Related]
6. MicroRNA regulation in experimental autoimmune encephalomyelitis in mice and marmosets resembles regulation in human multiple sclerosis lesions.
Lescher J; Paap F; Schultz V; Redenbach L; Scheidt U; Rosewich H; Nessler S; Fuchs E; Gärtner J; Brück W; Junker A
J Neuroimmunol; 2012 May; 246(1-2):27-33. PubMed ID: 22445295
[TBL] [Abstract][Full Text] [Related]
7. Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: A comprehensive overview.
Piket E; Zheleznyakova GY; Kular L; Jagodic M
J Autoimmun; 2019 Jul; 101():17-25. PubMed ID: 31014917
[TBL] [Abstract][Full Text] [Related]
8. Identification of the miRNA-mRNA regulatory network in multiple sclerosis.
Yang Q; Pan W; Qian L
Neurol Res; 2017 Feb; 39(2):142-151. PubMed ID: 27809691
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of translational regulation by microRNAs in multiple sclerosis.
Junker A
FEBS Lett; 2011 Dec; 585(23):3738-46. PubMed ID: 21453702
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis.
Thamilarasan M; Koczan D; Hecker M; Paap B; Zettl UK
Autoimmun Rev; 2012 Jan; 11(3):174-9. PubMed ID: 21621006
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis.
Talebi F; Ghorbani S; Chan WF; Boghozian R; Masoumi F; Ghasemi S; Vojgani M; Power C; Noorbakhsh F
J Neuroinflammation; 2017 Mar; 14(1):55. PubMed ID: 28302134
[TBL] [Abstract][Full Text] [Related]
12. miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis.
Naghavian R; Ghaedi K; Kiani-Esfahani A; Ganjalikhani-Hakemi M; Etemadifar M; Nasr-Esfahani MH
PLoS One; 2015; 10(5):e0124555. PubMed ID: 25938517
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of endothelial colony-forming cell function by a negative feedback loop of circulating miR-146a and -146b in cardiovascular disease patients.
Chang TY; Tsai WC; Huang TS; Su SH; Chang CY; Ma HY; Wu CH; Yang CY; Lin CH; Huang PH; Cheng CC; Cheng SM; Wang HW
PLoS One; 2017; 12(7):e0181562. PubMed ID: 28727754
[TBL] [Abstract][Full Text] [Related]
14. Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells.
Sanders KA; Benton MC; Lea RA; Maltby VE; Agland S; Griffin N; Scott RJ; Tajouri L; Lechner-Scott J
Clin Epigenetics; 2016; 8(1):87. PubMed ID: 27570566
[TBL] [Abstract][Full Text] [Related]
15. MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis.
Lecca D; Marangon D; Coppolino GT; Méndez AM; Finardi A; Costa GD; Martinelli V; Furlan R; Abbracchio MP
Sci Rep; 2016 Oct; 6():34503. PubMed ID: 27698367
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs as active players in the pathogenesis of multiple sclerosis.
Fenoglio C; Ridolfi E; Galimberti D; Scarpini E
Int J Mol Sci; 2012 Oct; 13(10):13227-39. PubMed ID: 23202949
[TBL] [Abstract][Full Text] [Related]
17. Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial.
Dolati S; Aghebati-Maleki L; Ahmadi M; Marofi F; Babaloo Z; Ayramloo H; Jafarisavari Z; Oskouei H; Afkham A; Younesi V; Nouri M; Yousefi M
J Cell Physiol; 2018 Jul; 233(7):5222-5230. PubMed ID: 29194612
[TBL] [Abstract][Full Text] [Related]
18. Genetic association and altered gene expression of mir-155 in multiple sclerosis patients.
Paraboschi EM; Soldà G; Gemmati D; Orioli E; Zeri G; Benedetti MD; Salviati A; Barizzone N; Leone M; Duga S; Asselta R
Int J Mol Sci; 2011; 12(12):8695-712. PubMed ID: 22272099
[TBL] [Abstract][Full Text] [Related]
19. Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.
Regev K; Healy BC; Khalid F; Paul A; Chu R; Tauhid S; Tummala S; Diaz-Cruz C; Raheja R; Mazzola MA; von Glehn F; Kivisakk P; Dupuy SL; Kim G; Chitnis T; Weiner HL; Gandhi R; Bakshi R
JAMA Neurol; 2017 Mar; 74(3):275-285. PubMed ID: 28114622
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood.
Cox MB; Cairns MJ; Gandhi KS; Carroll AP; Moscovis S; Stewart GJ; Broadley S; Scott RJ; Booth DR; Lechner-Scott J;
PLoS One; 2010 Aug; 5(8):e12132. PubMed ID: 20711463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
